NO20080248L - Tablett inneholdende lite opploselig, aktiv bestanddel - Google Patents

Tablett inneholdende lite opploselig, aktiv bestanddel

Info

Publication number
NO20080248L
NO20080248L NO20080248A NO20080248A NO20080248L NO 20080248 L NO20080248 L NO 20080248L NO 20080248 A NO20080248 A NO 20080248A NO 20080248 A NO20080248 A NO 20080248A NO 20080248 L NO20080248 L NO 20080248L
Authority
NO
Norway
Prior art keywords
active ingredient
tablet containing
insoluble active
containing insoluble
tablet
Prior art date
Application number
NO20080248A
Other languages
English (en)
Norwegian (no)
Inventor
Shigeyuki Marunaka
Makoto Fukuta
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37570471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20080248(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20080248L publication Critical patent/NO20080248L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20080248A 2005-06-22 2008-01-14 Tablett inneholdende lite opploselig, aktiv bestanddel NO20080248L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005182415 2005-06-22
PCT/JP2006/312419 WO2006137443A1 (ja) 2005-06-22 2006-06-21 難溶性の有効成分を含有する錠剤

Publications (1)

Publication Number Publication Date
NO20080248L true NO20080248L (no) 2008-01-14

Family

ID=37570471

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080248A NO20080248L (no) 2005-06-22 2008-01-14 Tablett inneholdende lite opploselig, aktiv bestanddel

Country Status (17)

Country Link
US (1) US8821926B2 (pt)
EP (1) EP1900368B1 (pt)
JP (1) JP5220408B2 (pt)
KR (1) KR20080027783A (pt)
CN (1) CN101247805B (pt)
AU (1) AU2006260201B2 (pt)
BR (1) BRPI0611618A2 (pt)
CA (1) CA2612090C (pt)
CR (1) CR9632A (pt)
ES (1) ES2366381T3 (pt)
IL (1) IL187916A (pt)
MX (1) MX2007015783A (pt)
NO (1) NO20080248L (pt)
NZ (1) NZ564407A (pt)
RU (1) RU2420278C2 (pt)
WO (2) WO2007004425A1 (pt)
ZA (1) ZA200711048B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102813635A (zh) * 2006-08-10 2012-12-12 武田药品工业株式会社 药物组合物
WO2009084023A2 (en) * 2007-10-19 2009-07-09 Glenmark Generics Limited Amorphous ramelteon and process for the preparation thereof
PL2389164T3 (pl) * 2009-01-21 2015-01-30 Hoffmann La Roche Kompozycje farmaceutyczne zawierające prolek inhibitora polimerazy HCV
TWI438200B (zh) * 2009-02-17 2014-05-21 必治妥美雅史谷比公司 Ｃ型肝炎病毒抑制劑
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
CN103989643B (zh) * 2013-07-26 2018-10-30 武汉先路医药科技有限公司 含有雷美替胺和共聚维酮的片剂
CN104546746A (zh) * 2013-10-28 2015-04-29 南京长澳医药科技有限公司 一种雷美替胺片剂及其制备工艺
JP7576905B2 (ja) 2016-05-06 2024-11-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー バレリアン組成物及び関連方法
JP7407364B2 (ja) * 2019-02-12 2024-01-04 日本ジェネリック株式会社 ラメルテオン含有固形製剤
US20250381143A1 (en) * 2021-12-30 2025-12-18 Adlai Nortye Biopharma Co., Ltd. A solid pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
WO1997032871A1 (en) * 1996-03-08 1997-09-12 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
JPH11322584A (ja) * 1998-05-07 1999-11-24 Sawai Pharmaceutical Co Ltd ベザフィブラート徐放性製剤
US6348485B1 (en) * 1998-06-09 2002-02-19 Takeda Chemical Industries, Ltd. Method for treating or preventing sleep disorders
AU6589200A (en) * 1999-09-10 2001-04-17 Ranbaxy Laboratories Limited Extended release formulation of etodolac
AU2002214305A1 (en) * 2000-11-17 2002-05-27 Takeda Chemical Industries Ltd. Pharmaceutical preparation containing copolyvidone
JP4848558B2 (ja) * 2001-05-08 2011-12-28 トーアエイヨー株式会社 塩酸メトホルミン含有速放性錠剤
JP4754211B2 (ja) 2004-12-28 2011-08-24 ライオン株式会社 粒状医薬組成物及びその製造方法

Also Published As

Publication number Publication date
KR20080027783A (ko) 2008-03-28
JPWO2006137443A1 (ja) 2009-01-22
ZA200711048B (en) 2009-05-27
AU2006260201B2 (en) 2011-10-20
AU2006260201A1 (en) 2006-12-28
WO2007004425A1 (ja) 2007-01-11
US20090036522A1 (en) 2009-02-05
US8821926B2 (en) 2014-09-02
CN101247805B (zh) 2012-10-10
CN101247805A (zh) 2008-08-20
IL187916A0 (en) 2008-03-20
MX2007015783A (es) 2008-02-21
ES2366381T3 (es) 2011-10-19
RU2008102238A (ru) 2009-07-27
NZ564407A (en) 2011-03-31
BRPI0611618A2 (pt) 2011-05-31
RU2420278C2 (ru) 2011-06-10
EP1900368A1 (en) 2008-03-19
CA2612090C (en) 2014-06-10
WO2006137443A1 (ja) 2006-12-28
EP1900368B1 (en) 2011-05-11
CA2612090A1 (en) 2006-12-28
CR9632A (es) 2008-02-04
IL187916A (en) 2013-11-28
EP1900368A4 (en) 2009-08-12
JP5220408B2 (ja) 2013-06-26
HK1115315A1 (en) 2008-11-28

Similar Documents

Publication Publication Date Title
NO20052496L (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20062135L (no) Fenylderivater som PPAR-agonister
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
NO20064166L (no) Utvalgte CGRP-antagonister, deres fremstilling og deres anvendelse som medikanmenter
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
SE0001899D0 (sv) New compounds
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
NO20052493L (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
NO20081844L (no) Terapeutiske forbindelser
NO20082269L (no) Nye piperaziner som antimalariamidler
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
CR9632A (es) Tableta que contiene un ingrediente dificilmente soluble
WO2004100865A3 (en) New benzimidazole derivatives
NO20075637L (no) 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitet
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
TW200740424A (en) Taste masking dosage form
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
NO20085215L (no) Nye pyridinanaloger
NO20060969L (no) Benzoxazinon avledende sulfonamid forbindelser, deres fremstilling og anvedelse som medikamenter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application